17-Hydroxy Progesterone (Neonatal Screen) in Turbhe
51+ booked in last 3 daysOverview
The 17-hydroxyprogesterone (17-OHP) test is a blood test done on newborns to screen for congenital adrenal hyperplasia (CAH), a genetic disorder affecting the adrenal glands. 17-Hydroxy Progesterone is a crucial substance measured in this test. It is an essential precursor in hormone production, particularly cortisol, aldosterone, and sex hormones.
17-Hydroxy Progesterone (Neonatal Screen) Price in Turbhe
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the 17-Hydroxy Progesterone (Neonatal Screen) with a clear pricing structure
The price of 17-Hydroxy Progesterone (Neonatal Screen) in Turbhe is ₹ 540
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
This test is required to: identify at-risk babies at the earliest for congenital adrenal hyperplasia.
This is a screening test for newborn babies usually done within 48-72 hours of birth to detect Congenital Adrenal Hyperplasia .
Newborn Screening is a test that involves testing of infants at birth for certain genetically linked metabolic disorders which may affect baby’s physical, mental and intellectual development. This test checks for Congenital Adrenal Hyperplasia in the newborn using 17-OHP as the marker analyte.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.